SHOULDER INNOVATIONS, INC. Operating Income
SHOULDER INNOVATIONS, INC. (SI) reported Operating Income of -$10.04 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$10.04M.
- SHOULDER INNOVATIONS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$8.98M.
- SHOULDER INNOVATIONS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$8.50M.
- SHOULDER INNOVATIONS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$7.64M.
- SHOULDER INNOVATIONS, INC. operating income (loss) for fiscal 2025 was -$26.30M.
- SHOULDER INNOVATIONS, INC. operating income (loss) for fiscal 2024 was -$14.65M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$10.04M 10-Q · filed 2026-08-06 | -$19.01M 10-Q · filed 2026-08-06 | -$27.51M derived: sum of 3 quarters · filed 2026-08-06 | -$35.15M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$8.98M 10-Q · filed 2026-05-13 | -$17.48M derived: sum of 2 quarters · filed 2026-05-13 | -$25.12M derived: sum of 3 quarters · filed 2026-05-13 | -$30.98M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$8.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$16.14M derived: sum of 2 quarters · filed 2026-03-10 | -$22.00M derived: sum of 3 quarters · filed 2026-08-06 | -$26.30M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$7.64M 10-Q · filed 2025-11-12 | -$13.50M derived: sum of 2 quarters · filed 2026-08-06 | -$17.80M 10-Q · filed 2025-11-12 | -$21.33M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$5.86M 10-Q · filed 2026-08-06 | -$10.16M 10-Q · filed 2026-08-06 | -$13.69M derived: sum of 3 quarters · filed 2026-08-06 | -$17.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$4.29M 10-Q · filed 2026-05-13 | -$7.83M derived: sum of 2 quarters · filed 2026-05-13 | -$11.71M derived: sum of 3 quarters · filed 2026-05-13 | -$15.69M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$3.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$7.42M derived: sum of 2 quarters · filed 2026-03-10 | -$11.40M derived: sum of 3 quarters · filed 2026-03-10 | -$14.65M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$3.88M 10-Q · filed 2025-11-12 | -$7.86M derived: sum of 2 quarters · filed 2025-11-12 | -$11.12M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$3.98M 10-Q · filed 2025-09-09 | -$7.24M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |